IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+12.24%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
54.39%
Holding
91
New
53
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$9.75M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$9.6M |
| 3 |
Immunovant
IMVT
|
$8M |
| 4 |
APTO
Aptose Biosciences, Inc.
APTO
|
$5.73M |
| 5 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$5.47M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 91.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Aurinia Pharmaceuticals
AUPH
$1.58B
| $9.75M | 1.58% | +481,104 | New | +$9.75M |
|
|
SAGE
2
DELISTED
Sage Therapeutics
SAGE
| $9.6M | 1.56% | +133,000 | New | +$9.6M |
|
|
3
Immunovant
IMVT
$2.56B
| $8M | 1.3% | +504,117 | New | +$8M |
|
|
APTO
4
DELISTED
Aptose Biosciences, Inc.
APTO
| $5.73M | 0.93% | +1,009,735 | New | +$5.73M |
|
|
CHMA
5
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $5.47M | 0.89% | +1,103,297 | New | +$5.47M |
|
6
Ardelyx
ARDX
$1.53B
| $4.84M | 0.78% | +645,436 | New | +$4.84M |
|
|
OTIC
7
DELISTED
Otonomy, Inc.
OTIC
| $4.09M | 0.66% | +1,067,271 | New | +$4.09M |
|
8
Madrigal Pharmaceuticals
MDGL
$9.76B
| $4.08M | 0.66% | +44,770 | New | +$4.08M |
|
9
KalVista Pharmaceuticals
KALV
$678M
| $3.78M | 0.61% | +212,420 | New | +$3.78M |
|
10
KALA BIO
KALA
$78.8M
| $3.78M | 0.61% | +1,023,431 | New | +$3.78M |
|
11
TG Therapeutics
TGTX
$4.65B
| $3.51M | 0.57% | +316,200 | New | +$3.51M |
|
12
Assembly Biosciences
ASMB
$190M
| $3.22M | 0.52% | +157,468 | New | +$3.22M |
|
13
Xenon Pharmaceuticals
XENE
$2.98B
| $3.19M | 0.52% | +243,470 | New | +$3.19M |
|
|
ARQL
14
DELISTED
Arqule Inc
ARQL
| $2.97M | 0.48% | +148,930 | New | +$2.97M |
|
15
Avalo Therapeutics
AVTX
$122M
| $2.8M | 0.45% | +519,800 | New | +$2.8M |
|
16
Puma Biotechnology
PBYI
$254M
| $2.72M | 0.44% | +311,253 | New | +$2.72M |
|
17
AnaptysBio
ANAB
$569M
| $2.32M | 0.38% | +143,000 | New | +$2.32M |
|
18
BioXcel Therapeutics
BTAI
$59M
| $2.31M | 0.37% | +158,373 | New | +$2.31M |
|
19
Ocular Therapeutix
OCUL
$2.12B
| $2.2M | 0.36% | +557,659 | New | +$2.2M |
|
|
KDNY
20
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.17M | 0.35% | +1,838,528 | New | +$2.17M |
|
21
Ultragenyx Pharmaceutical
RARE
$2.89B
| $2.14M | 0.35% | +50,000 | New | +$2.14M |
|
|
CCXI
22
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.84M | 0.3% | +46,423 | New | +$1.84M |
|
|
MNK
23
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $1.79M | 0.29% | +512,000 | New | +$1.79M |
|
24
Ovid Therapeutics
OVID
$91M
| $1.45M | 0.24% | +350,000 | New | +$1.45M |
|
25
InflaRx
IFRX
$108M
| $1.42M | 0.23% | +359,128 | New | +$1.42M |
|